Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial
Titel:
Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial
Auteur:
Tap, William D Papai, Zsuzsanna Van Tine, Brian A Attia, Steven Ganjoo, Kristen N Jones, Robin L Schuetze, Scott Reed, Damon Chawla, Sant P Riedel, Richard F Krarup-Hansen, Anders Toulmonde, Maud Ray-Coquard, Isabelle Hohenberger, Peter Grignani, Giovanni Cranmer, Lee D Okuno, Scott Agulnik, Mark Read, William Ryan, Christopher W Alcindor, Thierry del Muro, Xavier F Garcia Budd, G Thomas Tawbi, Hussein Pearce, Tillman Kroll, Stew Reinke, Denise K Schöffski, Patrick